Recalled Junifen Medicine Poses No Health Risk

January 30, 2013

The Spanish Agency for Medicines and Health Products (AEMPS) has advised that any one who has already used some of the recalled batch of  Junifen  medicine is in no danger.

Tthe product “does not pose a health risk.”

AEMPS  ordered the removal of  Batch G07 of 4 percent Junifen oral suspension in 150 ml bottles,  an anti-inflammatory drug whose active ingredient is Ibuprofen and which is marketed by Reckitt Benckiser Healthcare.

On their website, the Agency specifies that this withdrawal is part of an annual control campaign undertaken with the collaboration of the health authorities of the various autonomous communities, to collect samples of different drugs that are  later investigated in AEMPS laboratories.

The recalled batch  ” did not conform to specifications,  specifically with regard to the yeast count.

The contamination of the drug by a higher yeast count than required does not have clinical implications for the patient since it is a micro-organism, which being orally administered would be destroyed by intestinal enzymes, said agency.

But they warn that the finding of such organisms could be interpreted, however, as suggestive of defective manufacture.”

If you have a some of the medicine out of this batch you can go to your pharmacy for return and / or exchange for another bottle from an unaffected batch .